“Luja is amazing. I mean, so truly, truly amazing. I never thought that I would be excited about a catheter in my life. Who knew?”
)
Full access to educational content, events and resources
Track your progress
Share content with your colleagues
Share supporting material with your patient
UTIs are a heavy burden for IC users and residual urine from incomplete bladder emptying is an important UTI risk factor1-4
In a controlled crossover study, 42 adult male CIC users were randomised for a health care professional-led catheterisation with Luja and a conventional eyelet catheter (CEC) in two individual test visits. The study compared the number of flow-stops and the residual urine at first flow-stop as co-primary endpoints.
The study found Luja had
No adverse events were observed in this study.
*Luja has close to no flow stops and complete bladder emptying is defined as <10 mL (NCT05485922, N=42). Individual results may vary.
**Compared to uncoated catheters
†Residual urine and microtrauma are UTI risk factors (Kennelly M., et al (2019), 10.1155/2019/2757862)
‡ Coloplast Data-on-File, Luja Male User Product Evaluation, 2023, n=816 (63/73 new users), NL, DK, CH, FI.